Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Structure Therapeutics Inc. Sponsored ADR (GPCR) had Return on Equity of -9.31% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-141.20M |
|
-- |
|
-- |
|
$176.56M |
|
$-176.56M |
|
$35.87M |
|
$-140.69M |
|
$-140.69M |
|
$-141.20M |
|
$-141.20M |
|
$-141.20M |
|
$-141.20M |
|
$-176.56M |
|
$-174.88M |
|
59.20M |
|
59.20M |
|
$-2.39 |
|
$-2.39 |
|
| Balance Sheet Financials | |
$1.57B |
|
$6.65M |
|
$13.62M |
|
$1.58B |
|
$63.28M |
|
-- |
|
$4.26M |
|
$67.54M |
|
$1.52B |
|
$1.52B |
|
$1.52B |
|
70.84M |
|
| Cash Flow Statement Financials | |
$-222.20M |
|
$89.80M |
|
$762.52M |
|
$169.51M |
|
$799.62M |
|
$630.11M |
|
$28.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-225.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-9.31% |
-9.31% |
|
-8.91% |
|
-9.31% |
|
$21.41 |
|
$-3.81 |
|
$-3.75 |
|